News & Events

News & Event

HealthCore acquisition of NERI strengthens pre-approval and special populations research

WILMINGTON, Del. & WATERTOWN, Mass. — HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc., today announced that it has acquired NERI, a privately-held, full-service contract research organization, to strengthen its pre-approval research capabilities.

“In addition to its experience in early phases of clinical trials, NERI’s unique experience in special populations, including pediatric and minority populations as well as rare, orphan, and underserved diseases, will allow HealthCore to broaden the scope of our real-world evidence development capabilities,” said Marcus Wilson, president of HealthCore. “NERI’s team has an expertise that complements our existing services, and in some cases, allows us to provide research services that we haven’t been able to offer in the past.”

View the full press release [PDF]

Comments are closed.